We could not find any results for:
Make sure your spelling is correct or try broadening your search.
THE WOODLANDS, Texas, July 25, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) will release its second quarter 2024 financial results on Thursday, August 1, 2024 after the...
Launch Preparations Actively Underway; Launch Planned for Early 2025 Lexicon Seeks Approval for Zynquista™ (sotagliflozin) as an Adjunct to Insulin Therapy for Glycemic Control in Adults with Type...
New analysis of the pivotal Phase 3 SOLOIST-WHF trial provides additional evidence of positive economic impact on hospitals participating in various alternative payment models (APM) Findings...
THE WOODLANDS, Texas, July 08, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that the Lexicon Board of Directors has appointed Mike Exton, Ph.D. as chief...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -11 | -10.1851851852 | 108 | 108 | 93 | 378 | 98.55311839 | DE |
4 | -4 | -3.9603960396 | 101 | 112 | 93 | 214 | 101.37419958 | DE |
12 | -30 | -23.6220472441 | 127 | 129.5 | 93 | 197 | 111.41413343 | DE |
26 | 95.695 | 7332.95019157 | 1.305 | 153 | 1.225 | 16839 | 2.63249357 | DE |
52 | 95.47 | 6239.86928105 | 1.53 | 153 | 1.04 | 21041 | 1.9145578 | DE |
156 | 94.455 | 3711.39489194 | 2.545 | 153 | 0.986 | 27074 | 1.68524968 | DE |
260 | 92.33 | 1977.08779443 | 4.67 | 153 | 0.986 | 32415 | 1.98314032 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions